China Otsuka Pharmaceutical Co., Ltd., founded in 1981, is a modern comprehensive enterprise integrating the production, sales, import and export trade of large infusions, ampoule injections, eye drops and nutritional infusions

China Otsuka Pharmaceutical Co., Ltd. is a subsidiary of China National Pharmaceutical Group Corporation, China Pharmaceutical Foreign Trade Corporation and Japan Otsuka Pharmaceutical Co., Ltd. jointly invested and established, approved in February 1981, officially put into operation on May 17, 1984, is China's first Sino-foreign joint venture pharmaceutical enterprises. At the end of 2009, Tianjin Pharmaceutical Group Co., Ltd. became one of the Chinese shareholders. China and Japan each hold 50% of the shares. The company's "COP" trademark has been rated as well-known protection, and has now become a comprehensive pharmaceutical manufacturer with COP brand infusion, ampoule injection, eye drops and nutritional infusion products, and has established 26 branches across the country, covering 30 provinces, cities and regions across the country, forming a nationwide sales network; And has two holding subsidiaries such as Guangdong Otsuka Pharmaceutical Co., Ltd. and Dalian Otsuka Pharmaceutical Co., Ltd. In 2012, the consolidated sales revenue exceeded 800 million yuan.

The company's headquarters is located in Xiqing District, Tianjin, and the factory covers an area of more than 10 million square meters.

The company has a number of production lines with the latest technology, capable of producing 46 varieties of soft bag infusion, plastic bottle infusion and plastic ampoule injection products in 4 categories, as well as a number of eye drops and nutritional infusion products. For more than 30 years, the product has been put on the market for more than 30 years, with advanced technology and strict management to ensure the quality and stability of clinical infusion products, without a single case of pyrogen reaction, and many indicators such as sterility and insoluble particles of infusion have been in a leading position for a long time, and the products have been rated as national and local high-quality products for many times, and are welcomed by the majority of medical workers and patients.

China Otsuka practices the corporate tenet of "continuously providing the latest and best quality products for human health" with practical actions, and will continue to make greater contributions to China's clinical infusion therapy.

Subsidiary: Guangdong Otsuka Pharmaceutical Co., Ltd. | Dalian Otsuka Pharmaceutical Co., Ltd